Advances in immunotherapy for triple-negative breast cancer.

Liu Y, Hu Y, Xue J, Li J, Yi J, Bu J, Zhang Z, Qiu P, Gu X

DOI: 10.1186/s12943-023-01850-7
Published: 2023 Sep 2
Container: Molecular cancer
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s12943-023-01850-7,
  title = {Advances in immunotherapy for triple-negative breast cancer.},
  author = {Liu Y and Hu Y and Xue J and Li J and Yi J and Bu J and Zhang Z and Qiu P and Gu X},
  year = {2023},
  journal = {Molecular cancer},
  doi = {10.1186/s12943-023-01850-7},
  url = {https://doi.org/10.1186/s12943-023-01850-7}
}

RIS

TY  - JOUR
TI  - Advances in immunotherapy for triple-negative breast cancer.
AU  - Liu Y
AU  - Hu Y
AU  - Xue J
AU  - Li J
AU  - Yi J
AU  - Bu J
AU  - Zhang Z
AU  - Qiu P
AU  - Gu X
PY  - 2023
JO  - Molecular cancer
DO  - 10.1186/s12943-023-01850-7
UR  - https://doi.org/10.1186/s12943-023-01850-7
ER  -

APA

Y, L., Y, H., J, X., J, L., J, Y., J, B., Z, Z., P, Q., & X, G. (2023). Advances in immunotherapy for triple-negative breast cancer.. Molecular cancer. https://doi.org/10.1186/s12943-023-01850-7

Source records

pubmed · retrieved 2026-11-10T18:05:36.609Z